School of Pharmacy

Shelly Gray

Shirley & Herb Bridge Endowed Professor, Department of Pharmacy; Director, Plein Center for Geriatric Pharmacy Research, Education and Outreach School of Pharmacy

CHOICE Faculty, Department of Pharmacy, Institute for Innovative Pharmacy Practice, Pharmacy Faculty, Plein Center in Geriatrics Faculty

Telephone: (206) 616-5061


Office Location: H361-D Box 357630 1959 NE Pacific St Seattle, WA 98195-7630

Website: PubMed


  • PharmD, University of Michigan
  • Masters of Science in Epidemiology, University of Washington
  • Pre-Pharmacy, University of Michigan

Research Interests

  • Pharmaceutical care for the elderly living in a community setting
  • Frailty and physiology of aging

Courses Taught

  • Pharm 549: Pharmacotherapeutics for Older Adults
  • Pharm 561: Pharmacotherapeutics IV


Dr. Gray has been a faculty member in the UW Department of Pharmacy since 1992. She is an investigator on numerous federally funded research grants and is author of more than sixty peer-reviewed publications. Earlier in her career, she received an American Association of Colleges of Pharmacy New Investigator Award and a Career Development Award from the National Institute on Aging. She serves on the editorial board for the “Annals of Pharmacotherapy”, “Journal of the American Geriatrics Society” and “Research in Gerontological Nursing”.

Gray has served as a consultant pharmacist for Providence Elderplace. Previously, she completed a two-year fellowship in geriatrics at the University of North Carolina at Chapel Hill and a clinical pharmacy residency at Thomas Jefferson University Hospital in Philadelphia. She has served on various committees of pharmacy and geriatric professional organizations.

Selected Publications

Lo-Ciganic WH, Boudreau R, Gray SL, Zgibor JC, Donohue JM, Perera S, Newman AB, Simonsick E, Bauer DC, Satterfield S, Hanlon JT. Changes in cholesterol-lowering medications use over a decade in community-dwelling older adults. Ann Pharmacother. 2013 Jul-Aug;47(7-8):984-92.

Gray SL, Anderson ML, Hubbard RA, LaCroix A, Crane PK, McCormick W, Bowen JD, McCurry SM, Larson EB. Frailty and Incident Dementia. J Gerontol A Biol Sci Med Sci. 2013 Sep;68(9):1083-90.

Peron EP, Zheng Y, Perera S, Newman AB, Resnick NM, Shorr RI, Bauer DC, Simonsick EM, Gray SL, Hanlon JT, Ruby CM, for the Health, Aging and Body Composition (Health ABC) Study. Antihypertensive drug class use differential risk of urinary incontinence in community-dwelling older women. J Gerontol A Biol Sci Med Sci. 2012 Dec;67(12):1373-8.

Gray SL, Aragaki A, Lamonte MJ, Cochrane BB, Kooperberg CL, Robinson JG, Woods NF, LaCroix AZ. Statins, angiotensin-converting enzyme inhibitors and physical performance in older women. J Am Geriatr Soc. 2012 Dec;60(12):2206-14.

Lakey SL, LaCroix AZ, Gray SL, Borson S, Williams CD, Calhoun D, Goveas JS, Smoller JW, Ockene JK, Masaki KJ, Coday MC, Rosal MC, Woods NF. Antidepressant use, Depressive Symptoms, and Incident Frailty in Women Aged 65 and Older from the Women’s Health Initiative Observational Study.  Am Geriatr Soc. 2012 May;60(5):854-61.

McDermott C, Gray SL. Cholinesterase inhibitor adjunctive therapy for cognitive impairment and depressive symptoms in older adults with depression. Ann Pharmacother. 2012 Apr;46(4):599-605.

Peron EP, Gray SL, Hanlon JT. Medication use and functional status decline in older adults: A narrative review. Am J Geriatr Pharmacother. 2011 Dec;9(6):378-91.

Gray SL, Boudreau RM, Newman AB, Studenski SA, Shorr RI, Bauer DC, Eleanor M. Simonsick EM, Hanlon JT. Angiotensin-converting enzyme inhibitor and statin medication use and incident mobility limitation in community older adults. The Health, Aging and Body Composition Study. J Am Geriatr Soc. 2011 Dec;59(12):2226-32.

Boudreau DM, Yu O, Gray SL, Raebel MA, Johnson J, Larson EB. Concomitant use of cholinesterase inhibitors and anticholinergics: prevalence and outcomes. J Am Geriatr Soc. 2011 Nov;59(11):2069-76.

Gray SL, Walker R, Dublin SA, Haneuse S, Crane PK, Breitner JC, Bowen J, McCormick W, Larson EB. Histamine-2 receptor antagonist use and incident dementia in an older cohortJ Am Geriatr Soc. 2011 Feb;59(2):251-7.